[논문]한의기반 통합암치료를 통한 재발성 담낭암 환자의 증상 호전 증례보고

고은주; 도성국; 박지혜; 송시연; 이연월; 유화승

doi:10.22246/jikm.2022.43.3.477

한의기반 통합암치료를 통한 재발성 담낭암 환자의 증상 호전 증례보고
A Case Report of Symptom Improvement with Recurrent Gallbladder Cancer Patients Treated with Korean Medicine-based Integrative Cancer Treatment 원문보기

대한한방내과학회지 = The journal of internal Korean medicine, v.43 no.3, 2022년, pp.477 - 484

고은주 (대전대학교 대전한방병원 동서암센터) , 도성국 (대전대학교 한의과대학 비계내과학교실) , 박지혜 (대전대학교 서울한방병원 동서암센터) , 송시연 (대전대학교 대전한방병원 동서암센터) , 이연월 (대전대학교 천안한방병원 동서암센터) , 유화승 (대전대학교 서울한방병원 동서암센터)

Abstract ▼ AI-Helper

Objective: The purpose of this study was to report the improvement effect of symptoms of integrative cancer treatment (ICT) on recurrent gallbladder cancer patients. Methods: A 73-year-old patient with recurrent gallbladder cancer visited the Daejeon Korean Medicine Hospital of Daejeon University East West Cancer Center (EWCC) on February 2022. After the diagnosis of gallbladder cancer, the patient underwent cholecystectomy and relapsed during follow-up. After the operation, the cancer recurred during follow-up, and after radiation treatment, she had been receiving ICT since February 2022. The clinical outcomes were measured by X-ray, computed tomography (CT), laboratory findings, including tumor markers (CEA, CA19-9), and numeric rating scales (NRS). Results: After treatment, abdominal pain was relieved from NRS 5 to 2, and abdominal circumference decreased from 74.5 to 67. During and after treatment, we found neither hepatotoxicity nor nephrotoxicity in the laboratory findings. Conclusion: This case study suggests that ICT may improve symptoms in patients with gallbladder cancer.

주제어

표/그림 (6)

그림 Fig. 1. Comparison of abdomen computed tomography. A : Aggravated ascites (2022/02/03) B : Recurrence at the surgical site is not prominent, Revenge is still observed, but has been greatly reduced (2022/04/14)
표 Table 1. Prescription of Herbal Medication
표 Table 2. Laboratory Findings
그림 Fig. 2. Comparison of abdomen erect X-ray. A : No significant abnormal gas pattern, no definite noted ileus sign, ascites collection (2022/02/12) B : No significant abnormal gas pattern, no definite noted ileus sign, ascites collection, mild (2022/04 /08)
그림 Fig. 3. Changes in abdominal circumference. Abdominal circumference decreased from 74.5 cm to 67 cm.
그림 Fig. 4. Changes of numeric rating scale on clinical symptom. Numeric rating scale of abdominal pain decreased from NRS 5 to NRS 2.

참고문헌 (24)

Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist 2010;15(2):168-81.

상세보기
Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4(3):167-76.

상세보기
Bergquist JR, Shah HN, Habermann EB, Hernandez MC, Ivanics T, Kendrick ML, et al. Adjuvant systemic therapy after resection of node positive gallbladder cancer: time for a well-designed trial. Int J Surg 2018;52:171-9.
Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, Ethun CG, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) 2016;18(11):872-8.

상세보기
Wi Y, Woo H, Won YJ, Jang JY, Shin A. Trends in gallbladder cancer incidence and survival in Korea. Cancer Res Treat 2018;50(4):1444-51.

상세보기
Jung KW, Won YJ, Hong S, Kong HJ, Lee ES. Prediction of cancer incidence and mortality in Korea, 2020. Cancer Res Treat 2020;52(2):351-8.

상세보기
Kim TG. Patterns of initial failure after resection for gallbladder cancer. implications for adjuvant radiotherapy. Radiat Oncol J 2017;35(4):359-67.

원문보기 상세보기
Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) 2016;18(11):872-8.

상세보기
Rakic M, Patrlj L, Kopljar M, Klicek R, Kolovrat M, Loncar B, et al. Gallbladder cancer. Hepatobiliary Surg Nutr 2014;3(5):221-6.
Han D, Yang J, Xu F, Huang Q, Bai L, Wei YL, et al. Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database. Medicine 2020;99(31):e21322.
Park BK, Yoo HS, Lee YW, Han SS, Cho JH, Son CG, et al. Retrospective cohort analysis for lung cancer patients treated with Wheel Balance Therapy (WBT). Korean J Orient Int Med 2009;19(2):45-56.
Ma Z, Fan Y, Wu Y, Kebebe D, Zhang B, Lu P, et al. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment. International Journal of Nanomedicine 2019;14:2029-53.

상세보기
Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver 2012;6(2):172-87.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394-424.
Shih SP, Schulick RD, Cameron JL, Lillemoe KD, Pitt HA, Choti MA, et al. Gallbladder cancer: The role of laparoscopy and radical resection. Ann Surg 2007;245(6):893-901.

상세보기
Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist 2010;15(2):168-81.

상세보기
Benson AB, D'Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, et al. Hepatobiliary cancers, version 2. J Natl Compr Canc Netw 2014;12(8):1152-82.
Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen LH, Klumpen HJ, et al. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial. BMC cancer 2015;15:564.
Wang W, Sun Y, Li X, Li H, Chen Y, Tian Y, et al. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression. Oncology reports 2011;26(5):1143-8.

상세보기
Rho YS, Barrera I, Metrakos P, Kavan P. Complete resolution of metastatic gallbladder cancer after standard Gemcitabine-Cisplatin combination therapy. Cureus 2015;7(12):e415.

상세보기
Kang HJ, Park JH, Yoo HS, Park YM, Cho CK, Kang IC. Effects of HAD-B1 on the proliferation of A549 cisplatin-resistant lung cancer cells, Molecular Medicine Reports. Mol Med Rep 2018;17(5):6745-51.
Kang HJ, Park SJ, Park YM, Yoo HS, Kang IC. Inhibitory effects of HangAmDan-B1 (HAD-B1) on A549 lung cancer cell proliferation and tumor growth in a xenograft model. Journal of Scientific Research 2016;4(7):187-93.
Park SW, Kim DJ, Kwak MA, Byun JS, Lee JY. The case report about the effect of Injinolyungsangami on the jaundice, Ascites and Edema in Liver Cancer Patient. The journal of Jehan Oriental Medical Academ 2014;2(1):17-26.
Chen Z, Ni W, Yang C, Zhang T, Lu S, Zhao R, et al. Therapeutic effect of Amomum villosum on inflammatory bowel disease in rats. Frontiers in pharmacology 2018;9:639.

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증